Fundamentals for Allergy Therapeutics ( agy )
Current Price: 0.05
Market Cap: 246.27m
Price / Net Assets: -51.52
Internal Rate of Return: 5.48%
PE10 Ratio: -26.8
Dividend Yield: 0%
Currency: £ GBP
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | Average |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £60.95m | £72.77m | £84.33m | £78.2m | £73.72m | £49m | £43m | £41.96m | £63m |
| Revenue Growth | -16.24% | -13.71% | 7.84% | 6.08% | 50.45% | 13.95% | 2.48% | - | 7% |
| Profit / Loss | £-51.03m | £-13.78m | £2.89m | £7.06m | £3.47m | £-13m | £0.11m | £0.74m | £-8m |
| Profit Increase/Decrease | 270.32% | -576.82% | -59.07% | 103.46% | -126.69% | -11,918.18% | -85.14% | - | -1,770% |
| Profit / Sales Ratio | - | - | 3.43% | 9.03% | 4.71% | - | 0.26% | 1.76% | 2% |
| Earnings per Share | £-0.08 | £-0.02 | £0.00 | £0.01 | £0.01 | £-0.02 | £0.00 | £0.00 | £-0.01 |
| Total Debt | £73.18m | £35.18m | £39.56m | £42.44m | £30.94m | £26.36m | £16.23m | £13.33m | £34.65m |
| Net Assets | £-4.78m | £38.40m | £48.53m | £43.78m | £37.56m | £30.32m | £34.47m | £15.07m | £30.42m |
| Debt / Asset Ratio | 106.99% | 47.81% | 44.91% | 49.22% | 45.17% | 46.51% | 32.01% | 46.94% | 46.94% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |